Good news is that OPT does have good insurance coverage if trial misconduct is proven.
No one else has come up with better reason why SHORE and COAST control arms performed 70%+ better than any other trial over the last decade.
Worth noting that ph2b was a large trial which may support a potential filing with lucentis combo and post market surveillance etc
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
60.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $738.7M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| OPT (ASX) Chart |
Day chart unavailable